<DOC>
	<DOCNO>NCT00123695</DOCNO>
	<brief_summary>There increase interest myocardial abnormality follow central nervous system event , subarachnoid hemorrhage ( SAH ) . These cardiac abnormality include ECG change , decrease cardiac output , decrease blood pressure , specific cardiac enzyme elevation , segmental wall motion abnormality ( SWMA ) . Interestingly , wall motion abnormality ECG change show reversible , therefore dysfunction describe neurogenic myocardial stunning . The pathophysiology cardiac dysfunction follow SAH yet fully elucidate . Many report ( mainly case report ) publish , far study investigated frequency abnormality prospective manner , correlate occurrence different cardiac abnormality , assess clinical variable predict cardiac dysfunction . And limited number study related neurological outcome cardiac dysfunction .</brief_summary>
	<brief_title>Serial Echocardiography After Subarachnoid Hemorrhage</brief_title>
	<detailed_description>Objectives : Therefore , study objective : 1 ) Assessment frequency myocardial dysfunction ( segmental wall motion abnormality , cardiac-specific enzyme elevation , ECG change ) patient SAH . 2 ) Determination predictive clinical variable occurrence myocardial dysfunction follow SAH . 3 ) Impact myocardial dysfunction neurological prognosis : death , secondary cerebral ischemia , hydrocephalus rebleeding . Methods : For purpose serial echocardiogram ECGs obtain cardiac enzyme measure 200-400 patient admit hospital SAH four participate center . The clinical variable study predict cardiac dysfunction : medical history , CT-scan score , circulatory parameter , blood sample , medication , surgical intervention ( coil clip ) , neurological condition ( Glasgow Coma Scale ) . The echocardiogram , ECGs cardiac enzyme study determine independent prognostic value outcome SAH patient . Expected Results : As ECG change drop blood pressure know occur frequently , researcher expect find cardiac contractile dysfunction patient SAH occur frequently assume . Moreover , cardiac abnormality neurological prognostic significance study need early recognition treatment cardiac abnormality SAH , condition poor prognosis .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Takotsubo Cardiomyopathy</mesh_term>
	<mesh_term>Myocardial Stunning</mesh_term>
	<criteria>Diagnosed aneurysmal subarachnoid hemorrhage Admitted within 72 hour bleed No informed consent Patients patient ' family unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>Takotsubo cardiomyopathy</keyword>
	<keyword>Cardiac abnormality</keyword>
	<keyword>outcome</keyword>
</DOC>